Holen Sie sich die Stockscreener-App
0.3105
1.65%
-0.0052
Schlusskurs vom Vortag:
$0.3157
Offen:
$0.316
24-Stunden-Volumen:
1.17M
Relative Volume:
0.55
Marktkapitalisierung:
$7.91M
Einnahmen:
$486.00K
Nettoeinkommen (Verlust:
$-28.43M
KGV:
-0.1101
EPS:
-2.8189
Netto-Cashflow:
$-26.75M
1W Leistung:
+3.78%
1M Leistung:
-10.65%
6M Leistung:
-83.22%
1J Leistung:
-82.65%
1-Tages-Spanne:
$0.30
$0.3177
1-Wochen-Bereich:
$0.2805
$0.3299
52-Wochen-Spanne:
$0.2805
$4.30
Vyne Therapeutics Inc Stock (VYNE) Company Profile
Firmenname
Vyne Therapeutics Inc
Sektor
Branche
Telefon
800-775-7936
Adresse
685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER
Vergleichen Sie VYNE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VYNE
Vyne Therapeutics Inc
|
0.3105 | 7.82M | 486.00K | -28.43M | -26.75M | -2.8189 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Vyne Therapeutics Inc Stock (VYNE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-31 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-11-18 | Eingeleitet | BTIG Research | Buy |
| 2021-12-06 | Fortgesetzt | H.C. Wainwright | Buy |
Vyne Therapeutics Inc Aktie (VYNE) Neueste Nachrichten
Relative strength of VYNE Therapeutics Inc. in sector analysisTrade Volume Report & Real-Time Sentiment Analysis - Newser
VYNE Therapeutics Faces Nasdaq Non-Compliance Notice - MSN
VYNE Therapeutics Inc. stock outlook for YEARJuly 2025 WrapUp & Entry Point Strategy Guides - Newser
Trend analysis for VYNE Therapeutics Inc. this weekBuy Signal & High Accuracy Buy Signal Tips - Newser
Ranking VYNE Therapeutics Inc. among high performing stocks via toolsFed Meeting & Weekly Momentum Picks - Newser
What moving averages say about VYNE Therapeutics Inc.2025 Top Decliners & Entry Point Confirmation Alerts - Newser
Analyzing recovery setups for VYNE Therapeutics Inc. investorsJuly 2025 Retail & Risk Adjusted Buy/Sell Alerts - Newser
Using economic indicators to assess VYNE Therapeutics Inc. potentialMarket Growth Report & Expert Approved Momentum Trade Ideas - Newser
News impact scoring models applied to VYNE Therapeutics Inc.July 2025 Opening Moves & Entry and Exit Point Strategies - Newser
Candlestick signals on VYNE Therapeutics Inc. stock todayEarnings Miss & Real-Time Sentiment Analysis - Newser
Is VYNE Therapeutics Inc. stock poised for growthPortfolio Gains Summary & Community Consensus Picks - Newser
Key resistance and support levels for VYNE Therapeutics Inc.2025 Historical Comparison & AI Driven Stock Movement Reports - Newser
How to interpret RSI for VYNE Therapeutics Inc. stock2025 Investor Takeaways & High Accuracy Swing Entry Alerts - Newser
Chart overlay techniques for tracking VYNE Therapeutics Inc.Earnings Recap Report & Weekly Watchlist for Consistent Profits - Newser
Institutional scanner results for VYNE Therapeutics Inc.July 2025 Decliners & Weekly Top Performers Watchlists - Newser
Technical analysis overview for VYNE Therapeutics Inc. stock2025 Investor Takeaways & Free Fast Entry Momentum Trade Alerts - Newser
VYNE Therapeutics Inc. stock momentum explainedWeekly Market Report & High Yield Stock Recommendations - Newser
Is VYNE Therapeutics Inc. reversing from oversold territoryVolume Spike & Weekly Breakout Watchlists - Newser
vyne therapeutics inc. stock outlook for yearWeekly Gains Report & Daily Oversold Bounce Ideas - Newser
Why VYNE Therapeutics Inc. is moving todayIndex Update & Low Risk High Reward Ideas - Newser
Will VYNE Therapeutics Inc. price bounce be sustainable2025 Performance Recap & Reliable Intraday Trade Plans - Newser
Using data models to predict VYNE Therapeutics Inc. stock movementMarket Sentiment Summary & AI Optimized Trading Strategy Guides - Newser
Is VYNE Therapeutics Inc. stock showing strong momentumJuly 2025 Trends & Stepwise Entry and Exit Trade Signals - Lancaster City Council
How to manage a losing position in VYNE Therapeutics Inc.2025 Key Lessons & Technical Pattern Based Signals - Newser
What to do if you’re stuck in VYNE Therapeutics Inc.July 2025 Drop Watch & Daily Market Momentum Tracking - Newser
Is it time to cut losses on VYNE Therapeutics Inc.2025 Trading Volume Trends & Real-Time Volume Spike Alerts - Newser
ranking vyne therapeutics inc. among high performing stocks via toolsJuly 2025 Technicals & Real-Time Volume Triggers - Newser
Price action breakdown for VYNE Therapeutics Inc.Portfolio Gains Report & Low Risk High Win Rate Stock Picks - Newser
Finanzdaten der Vyne Therapeutics Inc-Aktie (VYNE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):